Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Glucagon-like peptide-1 analogue-eluting beads - CellMed

Drug Profile

Glucagon-like peptide-1 analogue-eluting beads - CellMed

Alternative Names: CellBead Cardio; CellBead Neuro; CellBead-GLP-1; CM1-eluting bead; GLP-1 CellBead; GLP-1-eluting bead

Latest Information Update: 08 Apr 2014

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator CellMed
  • Class Glucagon-like peptides
  • Mechanism of Action Glucagon like peptide 1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Discontinued Cardiovascular disorders; Stroke

Most Recent Events

  • 08 Apr 2014 Discontinued - Phase-I for Cardiovascular disorders in United Kingdom (Intra-arterial)
  • 08 Apr 2014 Discontinued - Phase-I/II for Stroke in Germany (Intracerebral)
  • 01 Jun 2011 Phase-I clinical trials in Cardiovascular disorders in United Kingdom (Intra-arterial)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top